首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiven
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiven
admin
2012-05-18
40
问题
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiveness have been demonstrated and of which the Food and Drug Administration (FDA) has approved, or so-called "approved uses". Other uses have come to be called "unapproved uses" and cannot be legally promoted. In a real sense, the term "unapproved" is a misnomer because it includes in one phrase two categories of marketed drugs that are very different; drugs which are potentially harmful and will never be approved, and already approved drugs that have "unapproved" uses. It is common for new research and new insights to demonstrate valid new uses for drugs already on the market. Also, there are numerous examples of medical progress resulting from the serendipitous observations and therapeutic innovations of physicians, both important methods of discovery in the field of therapeutics. Before such advances can result in new indications for inclusion in drug labeling, however, the available data must meet the legal standard of substantial evidence derived from adequate and well-controlled clinical trials. Such evidence may require time to develop, and, without initiative on the part of the drug firm, it may not occur at all for certain uses. However, because medical literature on new uses exists and these uses are medically beneficial, physicians often use these drugs for such purposes prior to FDA review or changes in labeling. This is referred to as "unlabeled uses" of drugs.
A different problem arises when a particular use for a drug has been examined scientifically and has been found to be ineffective or unsafe, and yet physicians who either are uninformed or who refuse to accept the available scientific evidence continue to use the drug in this way. Such use may have been reviewed by the FDA and rejected, or, in some cases, the use may actually be warned against in the labeling. This subset of uses may be properly termed "disapproved uses."
Government policy should minimize the extent of unlabeled uses. If such uses are valid? and many are? it is important that scientifically sound evidence supporting them be generated and that the regulatory system accommodate them into drug labeling. Continuing rapid advances in medical care and the complexity of drug usage, however, makes it impossible for the government to keep drug labeling up to date for every conceivable situation. Thus, when a particular use of this type appears, it is also important, and in the interest of good medical care, that no stigma be attached to "unapproved usage" by practitioners while the formal evidence is assembled between the time of discovery and the time the new use is included in the labeling. In the case of "disapproved uses," however, it is proper policy to warn against these in the package insert, whether use of a drug for these purposes by the uninformed or intransigent physician constitutes a violation of the current Federal Food, Drug and Cosmetic Act is a matter of debate that involves a number of technical and legal issues. Regardless of that, the inclusion of disapproved uses in the form of contraindications, warnings and other precautionary statements in package inserts is an important practical deterrent to improper use. Except for clearly disapproved uses, however, it is in the best interests of patient care that physicians not be constrained by regulatory statutes from exercising their best judgment in prescribing a drug for both its approved uses and any unlabeled uses it may have.
Which of the following is true with disapproved drugs?
选项
A、There is nothing to prove that such drugs are not safe.
B、It is affirmative that such drugs are ineffective and dangerous.
C、Physicians do not intend to use such drugs.
D、Such drugs have never been tested by FDA
答案
B
解析
细节判断题。在文章第二段中,作者提到在药品使用过程中会出现一些问题,如有些药被检测无效或不安全,但有些医生不知情或不接受检测结果而继续使用此类药物。因此,只有答案B是正确的。其他选项与文章意思相反,故不正确。
转载请注明原文地址:https://kaotiyun.com/show/wAiO777K
0
专业英语八级
相关试题推荐
Ethnographyisthestudyofaparticularhumansocietyortheprocessofmakingsuchastudy.Contemporaryethnographyisbased
Foralongtimewehaveworkedhardatisolatingtheindividualfamily.Thishasincreasedthemobilityofindividuals;andbye
EconomicconditionshaveimprovedduringthepastdecadeinmanyNorthAmericanandEuropeanCBDs,primarilybecauseofanunpre
WhichofthefollowingsportswasNOTinventedinBritain?
TheBritishreporterYvonneRidleyisthankfullynowhomewithhernine-year-olddaughter,Daisy,followingherreleasefromcap
Abouthalfoftheinfantandmaternaldeathsindevelopingcountriescouldbeavoidedifwomenhad【M1】______usedfamilyplannin
Somepeoplesaythatcensorshipshouldbecancelledcompletely.Doyouagreeordisagreewiththestatement?Giveyourspecific
AccordingtoBloomfield,meaningcanbedefinedintermsofobservablestimuliandresponsesmadebyparticipantsinspecificsi
TheEnglishVocabularyVocabularyisacompleteinventoryofthewordsinalanguage.Itcanbedividedintoactivevocabulary
Dr.MartinLutherKing,______,wasassassinatedinMarch196
随机试题
县医院欲开展结扎手术和终止妊娠手术,须经哪一级部门批准
耳朵:赫兹
适用于挖掘浅且短的路堑的施工方法是()。
电子信息系统机房选址时,数据中心内放置计算机的机房不宜超过()。
黄河公司运用标准成本系统计算甲产品成本,有关资料如下:(1)本期单位产品直接材料的标准用量为5千克,单位材料的标准价格为2元,单位产品的标准工时为4小时,预计标准总工时为2000小时,标准工资总额为6000元,标准制造费用总额为7200元(其中变动
甲公司获得了A产品的实用新型专利,不久后乙公司自行研制出了与甲公司专利相同的A产品,并大规模生产;丙公司从乙公司处批发购进A产品100箱,并将其中的20箱提供给丁公司办公使用;乙公司、丙公司和丁公司对甲公司已经获得A产品的专利一事均不知情。根据专利法律制度
关于行政法规起草的规定,下列哪些说法是正确的?()
()是指工作结果对组织有重大影响的活动或大量的重复性活动。
文慧是新东方学校的人力资源培训讲师,负责对新入职的教师进行入职培训,其PowerPoint演示文稿的制作水平广受好评。最近,她应北京节水展馆的邀请,为展馆制作一份宣传水知识及节水工作重要性的演示文稿。节水展馆提供的文字资料及素材参见“水资源利用与节水(
A、Itcanprintoutsoftobjectsonly.B、Itbuildsupsolidobjectslayerbylayer.C、Itgivesa3Dimageofanobject’sstructur
最新回复
(
0
)